Lung Cancer Research Review, Issue 6

In this Issue:

Tecemotide for lung cancer immunotherapy?
Standard of care best for limited-stage SCLC
Potential health consequences of reducing home ventilation
EarlyCDT®-Lung testing for early lung cancer
Screening exhaled breath condensate for NSCLC
Axitinib-containing regimen in advanced NSCLC
BRAF-mutated lung carcinomas: clinicopathological features
Overcoming acquired crizotinib resistance
Rash: surrogate marker of erlotinib activity?
Clinician messages that encourage tobacco cessation

Please login below to download this issue (PDF)